Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2022 Feb 9;2(2):e0000189. doi: 10.1371/journal.pgph.0000189

Healthcare provider-to-patient perspectives on the uptake of teleconsultation services in the Nigerian healthcare system during the COVID-19 pandemic era

Ifeanyi Jude Ezeonwumelu 1,*,#, Ifeanyi Jude Obijiaku 2, Chukwudi Martin Ogbueche 3; Reunlearn360 2020 Cohort, Ucheoma Nwaozuru 4,*,#
Editor: Joao Tiago da Silva Botelho5
PMCID: PMC10021919  PMID: 36962178

Abstract

The urgency to curtail the devastating effects of the ongoing COVID-19 Pandemic has led to the implementation of several measures to limit its spread, including movement restrictions and social distancing. As most developing countries rely solely on hospital visitations for their medical needs, this impediment to assessing healthcare services compounded by low uptake of telehealth services could result in dire consequences. This is a cross-sectional study among Healthcare providers (HCP) and Healthcare consumers (HCC) in Nigeria. We administered a pre-validated self-administered online questionnaire comprising questions to assess the knowledge, use, perceptions, and benefits of telemedicine among study participants. Descriptive statistics were used to examine participants’ perceptions on telemedicine use and to summarize participants’ characteristics. A total of 158 healthcare providers and 1381 healthcare consumers completed the online survey. Ninety percent of HCP reported that they used some form of telemedicine to deliver health care, and 63% of HCC had received healthcare through telemedicine. A significant proportion of HCP (62%) and HCC (69%) agreed that telemedicine would improve healthcare consultation experience and satisfaction. However, fewer (21%) HCP agreed that they liked that there would be no physical contact with patients using telemedicine. In contrast, 52% of HCC agreed that they liked that there would be no physical contact with healthcare providers while using telemedicine. The majority of the participants believed that benefits of telemedicine would include: being a safe way for healthcare delivery during pandemics (HCP = 62%, HCC = 83%), affordability (HCP = 62%, HCC = 82%), and time-saving (HCP = 54%, HCC = 82%,). Teleconsultation services have been shown to aptly complement face-to-face hospital visits in ensuring effective triaging in hospitals and providing adequate healthcare delivery to patients regardless of geographical and physical barriers. These results support telemedicine use for the provision of healthcare services during the COVID-19 pandemic.

Introduction

The ongoing COVID-19 Pandemic has necessitated the urgent and crucial need to adopt strategies in the healthcare sector that seek to minimize face-to-face consultations, triage hospital visitations, and opt for teleconsultations whenever possible to limit the spread of the SARS-CoV-2 virus [1, 2]. The adoption of telehealth services during this Pandemic has ensured the continuity of healthcare delivery–breaking down physical and geographical barriers to assessing medical care even as most countries worldwide enforced movement restrictions and physical distancing measures aimed at reducing community nosocomial spread [3, 4].

Telehealth refers to the delivery of health care services from healthcare providers (HCP) to patients separated by physical (geographical) distance using information communication technology (ICT) for the diagnosis and treatment of diseases and injuries, research, and evaluation. Telehealth services (teleconsultations), including HCP-to-patient and HCP-to-HCP communications, can be delivered synchronously (real-time telephone and video calls), asynchronously (patient portals and e-consults), and through virtual agents (chatbots) [5, 6]. Now, the world must have to adapt to this recent Pandemic; it is time we re-evaluated the emerging role of telehealth as a key player in healthcare service delivery and possibly, revisit the question recently posed by Duffy and Lee—whether face-to-face visits should become the second, third, or even last option rather than the first option for meeting routine patient needs [5].

Although the recent COVID-19 Pandemic has changed world economies and healthcare systems; on the contrary, it could have a knock-on effect on the rapid uptake of telehealth services [7, 8]. However, there is still a gap in the adoption of telehealth services between developed countries with robust and efficient healthcare facilities and developing countries with less efficient healthcare systems, which has become more evident during this Pandemic [9]. The projection of Africa as the next epicenter of the ongoing COVID-19 Pandemic is indeed worrisome given the devastation this Pandemic could cause to its vulnerable healthcare systems [10]. The region’s healthcare system is faced with limited health care facilities and health provider shortages [11]. Hence, as COVID-19 cases in Nigeria continues to surge [12], the increasing burden of this Pandemic to its fragile healthcare system and resources necessitates proactive measures to rescue its healthcare system from eventual collapse.

The uptake of teleconsultation services in the Nigerian healthcare system is yet to gain traction in recent times due to several challenges, including poor telecommunication infrastructure, socio-cultural influence, change resistance, lack of awareness, fear of privacy and confidentiality breaches, and impersonation due to quackery, medico-legal issues and willingness to pay for telehealth services [13, 14]. However, smartphone penetration in Nigeria has been increasing over the years, with over 196 million and 143 million active telephone and internet subscribers recorded in June 2020, corresponding to an increase of 12.6% and 17.2%, respectively, from a comparable period the previous year [15]. This trend is promising and could be leveraged to improve the teleconsultation infrastructure in Nigeria.

This study aimed to evaluate the perception of the acceptability and usefulness of teleconsultations in the Nigerian healthcare system from both the HCP and healthcare consumers’ (HCC) perspectives and determine the influential role of the COVID-19 Pandemic on the uptake of teleconsultation services in Nigeria.

Methods

This study was an observational, cross-sectional study using an online, self-administered questionnaire.

Study participants, sample size, and sampling

The Open-Source Epidemiologic Statistics for Public Health (OpenEpi), v.3.01 (updated 2013/04/06) was used to calculate the sample size for this survey. Here, we hypothesized that at a 95% confidence level, 50% of the respondents must have been exposed to teleconsultations and are twice as likely to have positive acceptability and perception towards the uptake of teleconsultation services. The required sample size was estimated to be 1034 respondents, and with an additional 30% contingency, 1345 respondents from the public were assumed as an appropriate sample size. Assuming an HCP: Patient ratio of 1:10 in Nigeria, an additional 135 respondents from the HCP population were targeted for the HCP survey. Data collection was performed online using the google forms survey tool (Alphabet Inc., California, USA). The call for participation was made on social media (WhatsApp, Telegram, Facebook, LinkedIn, and Twitter) and was open for 3 months or until the required sample size was reached (02/11/2020-31/12/2020). Participation in this survey was voluntary, anonymous and participants could exit the survey at any time.

Research instrument

The research instrument for this study includes two online self-developed questionnaires. Two sets of survey tools (S1 and S2 Surveys), one for each of the target respondent groups–HCP and HCC and was pre-validated by at least three independent reviewers followed by a pre-test survey of 200 respondents from the outpatient clinics at University of Benin Teaching Hospital (UBTH). The questionnaire consists of five sections: a) a consent and approval page, b) demography of respondents, c) healthcare background check, d) acceptability and usability of telephone-delivered medical consultations, e) teleconsultations during the COVID-19 Pandemic. Sections 4 and 5 of the questionnaires were structured as positively framed statements, with respondents being asked to rate their agreement with each statement on a 5-point Likert scale ranging from strongly agree to disagree strongly. In addition, to ascertain the willingness to pay for teleconsultations, respondents were asked to respond to a statement regarding an appropriate fee to pay for teleconsultations rated on a 5-point Likert scale, ranging from "50% more than the cost of a face-to-face hospital visitation" to "50% less than the cost of a face-to-face hospital visitation."

Data analysis

Data were summarized using Microsoft Excel 2019 and analyzed utilizing the Statistical Package for the Social Sciences (SPSS) software, v.22, and the OpenEpi. Data were analyzed using descriptive statistics and frequencies to examine the characteristics of study participants and their responses to the survey items. Data are presented as frequencies and proportions. Bivariate analyses were conducted to examine whether there were differences in participants’ responses to overall perceptions on telemedicine and benefits of telemedicine across participants’ demographic factors. For bivariate comparison, chi-square or Fisher’s exact for smaller sample groupings was used. For comparative analysis, participants perceptions were dichotomized by aggregating the categories “agree” and “strongly agree” to “agree” in the text, while “neutral”, “disagree” and “strongly disagree” were combined to “disagree.” Statistical significance was defined at the level of a p-value equal to or less than 0.05.

Ethical approval

This study was approved by the health research ethics committee of the University of Benin Teaching hospital with the protocol number: ADM/E22/A/VOL.VII/14830854. Per our study protocol, participation was completely voluntary. All questions were self-administered and anonymous. Participants were not compensated for completing the survey and were free to withdraw or not answer any questions they did not want to with no professional or other consequences. Informed consent (written) was obtained from all subjects involved in the study.

Results

Characteristics of healthcare providers

Of the 168 HCP who completed the response, 158 of them resided in Nigeria. The results are based on the 158 HCP who reside in Nigeria. The mean age of the HCP is 31years (S.D = 4.9). Most of the HCP were male 95(60%) and resided in the South-South region of Nigeria 67(42%). About half (52%) of the HCP practiced exclusively in public health systems, 16% exclusively in private health settings, and 32% practiced in a combination of public health and private health settings. The majority of the HCP 115(73%) had experience with telemedicine consultation over the phone and had experience with telemedicine involving video 28(17%). A summary of HCP characteristics is provided in Table 1.

Table 1. Healthcare providers characteristics (n = 158).

Variables n (%)
Age 30.5±4.9 (Mean±S.D)
Geopolitical Zone
 Northeast 5(3%)
 North-West 5(3%)
 North Central 7(4%)
 South-West 20(13%)
 South-East 54(34%)
 South-south 67(42%)
Gender
 Female 63(40%)
 Male 95(60%)
Highest Educational Qualifications
 MBBS+ PhD 1(1%)
 MBBS+ Masters 16(10%)
 Other Degrees 38(24%)
 MBBS 103 (65%)
Most Recent Professional Development Status
 Consultancy 4(3%)
 Residency 37(23%)
 Internship 45(29%)
 Other Trainings 72 (46%)
Healthcare Service Delivery setting
 Exclusively in private health settings 25(16%)
 In a combination of public health and private health settings 51(32%)
 Exclusively in public health system 82(52%)
Frequency treating patients in hospital/healthcare facility in the last 6 months before the COVID-19 Pandemic
 Infrequently, at most 1 in the last 6 months 4(3%)
 Somewhat frequently, between 2 and 5 times in the last 6 months 7(4%)
 Frequently; at least 1 per month 8(5%)
 None 13(8%)
 Very frequently; at least 1 per week 126(80%)
Frequency treating patients in hospital/healthcare facility since the onset of the COVID-19 Pandemic
 Infrequently, at most 1 in the last 6 months 5(3%)
 None 6(4%)
 Somewhat frequently, between 2 and 5 times in last 6 months 12(8%)
 Frequently; at least 1 per month 14(9%)
 Very frequently; at least 1 per week 121(77%)
Experience with telemedicine consultation
 Yes, via video over internet (e.g., WhatsApp, Skype) 10(6%)
 None 15(10%)
 Yes, over the Phone, Yes, via video over the internet (e.g., WhatsApp, Skype) 18(11%)
 Yes, over the Phone 115(73%)
A session of medical consultations over the phone should cost patients …
 50% more than the cost of a face-to-face hospital visitations 10(6%)
 25% more than the cost of a face-to-face hospital visitations 24(15%)
 The same cost as a face-to-face hospital visitation 37(23%)
 25% less than the cost of a face-to-face hospital visitations 42(27%)
 50% less than the cost of a face-to-face hospital visitations 45(29%)

Healthcare providers overall perceptions on telemedicine for healthcare delivery

Healthcare providers (HCP) who participated in the study expressed opinions regarding their perceptions on using telemedicine for healthcare delivery (Fig 1). The results are presented for participants who agreed or strongly agreed to the statements. Less than half of the HCP (45%, 71) indicated that they would be interested in healthcare services offering medical consultations over the phone for patients. A good number of the HCP (45%, 70) agreed or strongly agreed that they would only prefer to use teleconsultation services during pandemics such as COVID-19. Only a few participants (24%, 39) perceived that they would be as satisfied talking to patients over the phone as they would talking to a patient during an in-person consultation.

Fig 1. Overall perceptions on the use of telemedicine among healthcare providers.

Fig 1

Additionally, 62% (98) agreed or strongly agreed that video over the internet services such as WhatsApp, Skype, or Zoom will improve their teleconsultation experience and satisfaction. Forty-two percent (67) of the participants expressed that using a phone to consult with a patient and prescribe medications would be an easy process. Very few (21%, 34) of the HCP liked that there would be no physical contact with patients when consulting over the phone.

In this section, we also highlight the notable differences in perception of telemedicine use by HCP demographics. The bivariate categorical test shows no relationship with HCP’s age, location (geopolitical zone), gender, recent professional development status, and healthcare service delivery setting on their responses to the perception statements (whether they agreed or disagreed with perception statements). The only exception was the perception statement on whether HCP agreed or disagreed that videos would improve their teleconsultation experience and satisfaction. There was a statistically significant association between participants’ geopolitical zone and their responses to the aforementioned statement (p-value = 0.042). Likewise, there was a statistically significant association between participants’ current professional development status and their responses to the statement on if they agreed or disagreed that videos would improve their teleconsultation experience and satisfaction (p-value = <0.0001). A complete list of comparisons can be found in the S1 Table.

Healthcare providers perceptions on benefits of telemedicine for healthcare delivery

The majority of the HCP expressed opinions regarding the perceived benefits of using telemedicine for healthcare delivery (Fig 2). Most of the participants, 54% (86), indicated that delivering medical consultations and prescriptions to patients over the phone would help in saving the patients’ time. However, less than half (40%,64) indicated that delivering medical consultations and prescriptions to patients over the phone would be a convenient form of healthcare for patients. Sixty-four percent (102) of the participants expressed that using phones for healthcare service delivery during the COVID-19 Pandemic would be a safe strategy for patients to receive care. Additionally, sixty-one percent (96) of the participants indicated that using the phone would be an affordable way for patients to receive healthcare services during the COVID-19 Pandemic. Fifty-three percent (84) of participants either agreed or strongly agreed with the statement that using a phone would be a useful, practical, and effective way for patients to receive healthcare service from a doctor or health professional during the COVID-19 Pandemic.

Fig 2. Perception on the benefits of telemedicine among healthcare providers.

Fig 2

In addition, there were some notable differences in perception on the benefits of telemedicine use by HCP demographics. There was a statistically significant association between participants recent professional development status (p-value = 0.008), healthcare service delivery setting (p-value = 0.033), and if participants agreed or disagreed, using the phone would be a useful (practical) and effective way for patients to receive healthcare service from a Doctor/Health professional during COVID-19 pandemic. There was no relationship between this response and participants’ age, geopolitical zone, and gender. Also, participants’ recent professional development status and healthcare service delivery setting were associated with whether they agreed or disagreed that phone would be an affordable way for patients to receive healthcare services during the COVID-19 pandemic. Complete details of results can be found in the S2 Table.

Characteristics of healthcare consumers

A total of 1381 participants who were not physicians or HCP completed the survey. The mean age of the participants is 28.81 years (S.D = 6.3). The majority of the participants were male, 799(57.9%), and resided in the South-East region of Nigeria 560(40.6%). Most participants had a formal education with an almost equal split in non-scientific/non-medical and scientific/medical fields. The majority of the participants, 546(39.6%), visited a combination of public health and private health settings for their healthcare needs. About 42% (576) participants visited health facilities infrequently, at most once in six months preceding the COVID-19 Pandemic. Also, about half of the participants indicated that they did not experience more hospital cancellations or long-term rescheduling of appointments due to the pandemic. The majority of the participants, 510(37%), had never received telemedicine consultation during the data collection. The Summary of study participants’ characteristics is provided in Table 2.

Table 2. Healthcare consumers characteristics (N = 1381).

Variables n (%)
Age 28.81±6.3 (Mean±S.D)
Geopolitical Zone
 South-East 560(40.6)
 South-West 402 (29.1)
 South-South 282 (20.4)
 North-Central 90 (6.5)
 North-West 27 (2.0)
 North-East 14 (1.0)
Gender
 Male 799 (57.9)
 Female 573 (41.9)
Highest Education Level
 Bachelors 716 (51.9)
 Secondary 291 (21.1)
 Masters 283 (20.5)
 Doctorate 41 (3.0)
 Others 35 (2.5)
 No Formal Education 9 (0.7)
Academic Background
 Non-Scientific/Non-medical 686 (49.7)
 Scientific/Medical 689 (49.9)
Frequency in Visiting Health Facility 6 months Prior to the COVID-19 Pandemic
 Infrequently; at most 1 in the last 6 months 576 (41.7)
 None 315 (22.8)
 Somewhat frequently, between 2 and 5 in the last 6 months 182 (13.2)
 Very frequently; at least 1 per week 166 (12.0)
 Frequently; at least 1 per month 136 (9.9)
How frequently did you visit a hospital/healthcare facility since the onset of the COVID-19 Pandemic?
 None 503 (36.4)
 Infrequently, at most 1 in the last 6 months 483 (35.0)
 Somewhat frequently, between 2 and 5 in the last 6 months 162 (11.7)
 Very frequently; at least 1 per week 147 (10.7)
 Frequently; at least 1 per month 80 (5.8)
Had more Hospital visitation cancellations or long-term rescheduling of appointments since the COVID-19 Pandemic
 No 704 (51.0)
 Yes 510 (37.0)
 Maybe 161 (11.7)
Usual Healthcare Service Location
 In a combination of public health and private health settings 546 (39.6)
 Exclusively in private health settings 377 (27.3)
 Other (e.g., Pharmacy stores, Self-medication, Referrals, etc.) 294 (21.3)
 Exclusively in the public health system 158 (11.4)
Ever received telemedicine consultation
 None 510 (37.0)
 Yes, over the Phone 393 (28.4)
 Yes, over the Phone, Yes, via video over the internet (e.g., WhatsApp, Skype) 307 (22.2)
 Yes, via video over internet (e.g., WhatsApp, Skype) 165 (12.0)
A session of medical consultations over the phone should cost
 50% less than the cost of a face-to-face hospital visitations 480 (34.8)
 25% less than the cost of a face-to-face hospital visitations 530 (38.4)
 The same cost as a face-to-face hospital visitation 187 (13.6)
 25% more than the cost of a face-to-face hospital visitations 92 (6.7)
 50% more than the cost of a face-to-face hospital visitations 86 (6.2)

Healthcare consumers overall perceptions on telemedicine for healthcare delivery

Healthcare consumers who participated in the study expressed their perceptions of using telemedicine for healthcare services (Fig 3). The results are presented for participants who agreed or strongly agreed to the statements. Most of the participants agreed 774 (56%) that they would be interested in healthcare services offering medical consultations over the phone for patients. Fifty-eight percent of the participants agreed 576(42%) or strongly agreed 215(16%) that they would only prefer teleconsultation services during pandemics such as COVID-19. Most of the participants perceived that they would be satisfied talking to a healthcare provider over the phone as they would during in-person consultation (agree 659(48%); strongly agree 338(21%)).

Fig 3. Healthcare consumers overall perceptions on telemedicine use.

Fig 3

Healthcare consumers perceptions on benefits of telemedicine for healthcare delivery

Eighty-three percent (n = 1150) of the participants expressed that using phones to receive healthcare service during the COVID-19 Pandemic would be a safe strategy. The majority of the participants indicated that using a phone would be an affordable 1135(82%) and practical 1135(82%) way to receive healthcare service during the pandemic. Also, most of the participants, 82% (n = 1135), indicated that receiving medical consultations and prescriptions over the phone would help in saving time. Additionally, 69% (n = 954) of the participants agreed that receiving medical consultations over the phone would be convenient for them (Fig 4).

Fig 4. Healthcare consumers perception on the benefits of telemedicine use.

Fig 4

Comparison of healthcare providers and healthcare consumers responses on overall perceptions and benefits of telemedicine use

Table 3 presents the results of the bivariate comparison of HCP and HCC responses on overall perceptions of telemedicine use. There was a statistically significant association in the proportion of HCP and HCC who agreed to the overall telemedicine perception statements (p<0.05). The exception was for the proportion of HCP or HCC who agreed that they prefer to use teleconsultation services ONLY during pandemics. There was no statistically significant association in the proportion for the two groups (p = 0.497).

Table 3. Comparison of healthcare providers and health care consumers overall perceptions on telemedicine use.

Perceptions of Telemedicine Use Healthcare Providers Healthcare Consumers P-Value
Agreed that they liked that there would be no physical contact with receiving or delivering health service when consulting over the phone 34 (21.5) 708 (51.5) <0.001
Agreed that using the phone to consult will be easy for delivering or receiving health service 67 (42.4) 1085 (78.9) <0.001
Agreed that video over the internet will improve teleconsultation experience and satisfaction 98 (62.0) 1133 (82.4) <0.001
Agreed that they would be as satisfied receiving or delivering service over the phone as they would in a consulting room at a healthcare facility 39 (24.7) 957 (69.6) <0.001
Agreed that they prefer to use teleconsultation services ONLY during pandemics 86 (54.4) 791 (57.9) 0.497
Agreed that they would be interested in being involved in a service offering medical consultations over the phone 71 (44.9) 997 (72.5) <0.001

In addition, Table 4 presents the results of the bivariate comparison of HCP and HCC responses on the benefits of telemedicine use. There was a statistically significant association in the proportion of HCP and HCC who agreed to the benefits of telemedicine use statements (p<0.05).

Table 4. Comparison of healthcare providers and healthcare consumers perceptions on benefits of telemedicine use.

Benefits of Telemedicine Use Healthcare Providers Healthcare Consumers P-Value
Agreed that using phone would be a useful (practical) and effective way to deliver or receive healthcare service during COVID-19 Pandemic 84 (53.2) 1135 (82.5) <0.001
Agreed that using the phone would be an affordable way to receive or deliver healthcare services during COVID-19 Pandemic 96 (60.8) 1135 (82.5) <0.001
Agreed that using the phone would be a safe way to deliver or to receive healthcare services during COVID-19 Pandemic 102 (64.6) 1150 (83.6) <0.001
Agreed that delivering and receiving medical consultations and prescriptions would be a convenient form of healthcare delivery 64 (40.5) 954 (62.2) <0.001
Agreed that delivering and receiving medical consultations and prescriptions over the phone would save me time 94 (59.5) 1127 (82.0) <0.001

Discussion

Main findings

Telemedicine is garnering attention given the prominence of mobile technologies in sub-Saharan Africa countries, including Nigeria [16]. The emergence of the COVID-19 pandemic has further highlighted the need to consider telemedicine for healthcare delivery [17, 18]. This study explored healthcare providers’ and consumers’ perceptions of telemedicine utilization during Nigeria’s ongoing COVID-19 pandemic. Overall, the results suggest that HCP and HCC are receptive to the use of telemedicine for health consultation and found it to be a useful and practical tool. Most HCP had experience with telemedicine (90%), and fewer HCC (63%) had used telemedicine but believed telemedicine should be expanded beyond the COVID-19 Pandemic.

Comparison with previous work

Telemedicine service involving cellphone use appears to be the most popular form, with 84% of HCP and 50.6% of HCC reporting using this modality for teleconsultation or healthcare service. This is consistent with the study by Shittu et al. (2007) [19] in Lagos, Nigeria, where phones were the most popular form of telemedicine communication among study participants (85.9% of healthcare providers in the study).

Our study findings showed that HCP and HCC have favorable attitudes towards telemedicine use. This is congruent with previous studies in Nigeria [20] and other sub-Saharan African countries [21] that had assessed perceptions of telemedicine use. In addition, our study suggests that HCP and HCC perceived that telemedicine carried certain benefits for healthcare delivery. Most of the participants (both HCP and HCC) agreed that telemedicine could enhance the healthcare delivery experience by saving time and convenience. Specific to the healthcare delivery during the COVID-19 pandemic, most of the participants agreed that telemedicine would be an affordable, safe, and effective way to deliver or receive healthcare services. These benefits are similar to those in existing literature [22]. Notably, there were statistically significant differences in the proportions of HCP and HCC that agreed on the benefits of telemedicine use for healthcare service delivery. This difference in proportion could be attributed to differences between HCP and HCC overall knowledge of telehealth services. Ideally, HCP are more likely to be well informed about the challenges associated with the implementation of teleconsultation services in Nigeria more than the HCC, hence being more reluctant to acknowledge the uptake and benefits of these services. However, this difference in proportion could also be attributed to the difference in sample size between the two groups and might represent a confounding factor in this study.

Regarding participants’ views on the cost of telemedicine, there were mixed responses from HCP and HCC, with the majority from each group indicating the cost should be less than in-person healthcare service. Although this study did not assess the influence of cost on telemedicine uptake, previous studies have reported that HCP are less likely to use telemedicine services if they are not adequately compensated for their time and effort [23, 24]. Likewise, the affordability of telemedicine for HCC is a critical factor in telemedicine uptake [24].

Overall, findings from this study support the acceptability of telemedicine for healthcare service delivery and consultation. This underscores the need for future work to evaluate how the acceptability of telemedicine translates to the implementation and adoption of healthcare systems. A recent review highlights technological, organizational, legal and regulatory, individual, financial, and cultural aspects as key barriers to the successful implementation of telemedicine in sub-Saharan Africa [24]. Hence concerted efforts are needed to address these barriers to facilitate the adoption of telemedicine for healthcare delivery during and beyond the COVID-19 pandemic.

Strengths and limitations

The strengths of this study include, to the best of our knowledge, this is one of the first studies to explore the acceptability, perceptions of telemedicine among Nigerian HCP and the general public. This information is critical as we make sense of healthcare service delivery during the COVID-19 Pandemic and post-pandemic. Our study has some limitations worth noting. First, it is subject to selection bias due to the convenience sampling and recruitment approach. This means that the survey was limited to individuals who have smartphone devices and were technologically savvy to complete online surveys. This excludes the perspectives of individuals without access to the internet.

Therefore, findings from this study should be considered exploratory and may not be generalizable to the HCP and the public in Nigeria. However, considering the ongoing COVID-19 pandemic, this approach was the safest strategy and had the potential for a wider reach. Secondly, this study was also limited by the study’s cross-sectional design, which precludes the investigation of causal relationships. Particularly, follow-up research, using a longitudinal design, could determine to what extent specific telehealth applications continue and evolve over time and after the Pandemic, assessing their perceived benefits and challenges for healthcare provision in the long term. Thirdly, all data was collected using an online survey. Notwithstanding the limitations, the results of this study provide information regarding providers’ and individuals’ perceptions on the use of telemedicine due to the COVID-19 pandemic. This can inform relevant public health response. Other variables of interest to consider in future studies include additional information on the challenges and nuanced benefits. Despite these limitations, this study adds new and important information to the literature on perception, acceptability, and uptake of telemedicine in Nigeria.

Conclusions

Technology is playing an increasingly important role in enhancing patient healthcare access and delivery, particularly with the emergence of the ongoing COVID-19 pandemic. Telemedicine has been shown to aptly complement face-to-face hospital visits in ensuring effective triaging in hospitals and providing adequate healthcare delivery to patients regardless of geographical and physical barriers. In this study, most participants, HCP, and HCC expressed positive views towards telemedicine consultations. These results support telemedicine use for the provision of healthcare services during the COVID-19 pandemic. Future studies can investigate implementation strategies for the adoption of telemedicine and how perceptions evolve post COVID-19 pandemic.

Supporting information

S1 Survey. HCP questionnaire.

(DOCX)

S2 Survey. HCC questionnaire.

(DOCX)

S1 Checklist. PLOS questionnaire on inclusivity in global research.

(DOCX)

S1 Table. Results-association between healthcare providers demographic characteristics and perceptions on telemedicine use.

(DOCX)

S2 Table. Results-association between healthcare providers demographic characteristics and perceptions on benefits of telemedicine use.

(DOCX)

S3 Table. Results-association between healthcare consumers demographic characteristics and perceptions on telemedicine use.

(DOCX)

S4 Table. Results-association between healthcare consumers demographic characteristics and perceptions on benefits of telemedicine use.

(DOCX)

Acknowledgments

We thank all healthcare providers and healthcare consumers who participated in the study and the Reunlearn360 2020 Mentee cohort (Kikelomo Adetola Omotoye, Ebuka Samuel Anyaso, Fatima Zara Abdurahaman and Zainab Olamide Olaniyan) who helped in the survey dissemination.

Data Availability

All relevant data are within the manuscript and supplementary information.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Sutherland AE, Stickland J, Wee B. Can video consultations replace face-to-face interviews? Palliative medicine and the Covid-19 pandemic: rapid review. BMJ supportive & palliative care. 2020;10(3):271–5. doi: 10.1136/bmjspcare-2020-002326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Imlach F, McKinlay E, Middleton L, Kennedy J, Pledger M, Russell L, et al. Telehealth consultations in general practice during a pandemic lockdown: survey and interviews on patient experiences and preferences. BMC family practice. 2020;21(1):1–14. doi: 10.1186/s12875-019-1070-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al. Telehealth transformation: COVID-19 and the rise of virtual care. Journal of the American Medical Informatics Association. 2020;27(6):957–62. doi: 10.1093/jamia/ocaa067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Annis T, Pleasants S, Hultman G, Lindemann E, Thompson JA, Billecke S, et al. Rapid implementation of a COVID-19 remote patient monitoring program. Journal of the American Medical Informatics Association. 2020;27(8):1326–30. doi: 10.1093/jamia/ocaa097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Duffy S, Lee TH. In-person health care as option B. The New England journal of medicine. 2018;378(2):104–6. doi: 10.1056/NEJMp1710735 [DOI] [PubMed] [Google Scholar]
  • 6.CDC. Using Telehealth to Expand Access to Essential Health Services during the COVID-19 Pandemic. June 10, 2020. Updated: Accessed Feb. 2021;1.
  • 7.Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. New England Journal of Medicine. 2020;382(18):1679–81. doi: 10.1056/NEJMp2003539 [DOI] [PubMed] [Google Scholar]
  • 8.Schinköthe T, Gabri MR, Mitterer M, Gouveia P, Heinemann V, Harbeck N, et al. A web-and app-based connected care solution for COVID-19 in-and outpatient care: qualitative study and application development. JMIR public health and surveillance. 2020;6(2):e19033. doi: 10.2196/19033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Webster P. Virtual health care in the era of COVID-19. The Lancet. 2020;395(10231):1180–1. doi: 10.1016/S0140-6736(20)30818-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tshangela A, Salyer S, Varma J, Ouma A, Nkengasong J. COVID-19 in Africa: the spread and response. Nature Medicine. 2020. doi: 10.1038/s41591-020-0961-x [DOI] [PubMed] [Google Scholar]
  • 11.Willcox ML, Peersman W, Daou P, Diakité C, Bajunirwe F, Mubangizi V, et al. Human resources for primary health care in sub-Saharan Africa: progress or stagnation? Human resources for health. 2015;13(1):1–11. doi: 10.1186/s12960-015-0073-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.NCDC. Nigeria centre for Disease Control (NCDC). Confirmed COVID19 Cases—Nigeria 2020. https://covid19.ncdc.gov.ng/state/2020 [cited 2021 October 10 ].
  • 13.Adenuga K, Iahad N, Miskon S. Telemedicine system: service adoption and implementation issues in Nigeria. Indian Journal of Science and Technology. 2020;13(12):1321–7. [Google Scholar]
  • 14.Arize I, Onwujekwe O. Acceptability and willingness to pay for telemedicine services in Enugu state, southeast Nigeria. Digital health. 2017;3:2055207617715524. doi: 10.1177/2055207617715524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.NCC. Nigerian Communications Commission (NCC). Industry Statistics, 2020 https://www.ncc.gov.ng/stakeholder/statistics-reports/industry-overview#monthly2020.
  • 16.Wamala DS, Augustine K. A meta-analysis of telemedicine success in Africa. Journal of pathology informatics. 2013;4. doi: 10.4103/2153-3539.108542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 pandemic, lessons for the future. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd Floor New; 2020. [DOI] [PubMed] [Google Scholar]
  • 18.Bahl S, Singh RP, Javaid M, Khan IH, Vaishya R, Suman R. Telemedicine technologies for confronting COVID-19 pandemic: a review. Journal of Industrial Integration and Management. 2020;5(04):547–61. [Google Scholar]
  • 19.Shittu L, Adesanya O, Izegbu M, Oyewopo A, Ade A, Ashiru O. Knowledge and perception of health workers towards tele-medicine application in a new teaching hospital in Lagos. Scientific Research and Essay. 2007;2(1):016–9. [Google Scholar]
  • 20.Abodunrin O, Akande T. Knowledge and perception of e-health and telemedicine among health professionals in LAUTECH teaching hospital, Osogbo, Nigeria. International Journal of Health Research. 2009;2(1). [Google Scholar]
  • 21.Biruk K, Abetu E. Knowledge and attitude of health professionals toward telemedicine in resource-limited settings: a cross-sectional study in North West Ethiopia. Journal of healthcare engineering. 2018;2018. doi: 10.1155/2018/2389268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.WHO Global Observatory for eHealth. Telemedicine: opportunities and developments in Member States: report on the second global survey on eHealth. (2010). https://apps.who.int/iris/handle/10665/44497 [cited 2021 October 10].
  • 23.De Grood C, Raissi A, Kwon Y, Santana MJ. Adoption of e-health technology by physicians: a scoping review. Journal of multidisciplinary healthcare. 2016;9:335. doi: 10.2147/JMDH.S103881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dodoo JE, Al-Samarraie H, Alzahrani AI. Telemedicine use in Sub-Saharan Africa: Barriers and policy recommendations for Covid-19 and beyond. International Journal of Medical Informatics. 2021;151:104467. doi: 10.1016/j.ijmedinf.2021.104467 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0000189.r001

Decision Letter 0

Joao Tiago da Silva Botelho

17 Dec 2021

PGPH-D-21-00917

Healthcare provider-to-Patient perspectives on the uptake of Teleconsultation services in the Nigerian healthcare system in the COVID19 pandemic era

PLOS Global Public Health

Dear Dr. EZEONWUMELU,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 31 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Joao Tiago da Silva Botelho

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

2. We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type ‘LaTeX Source File’ and leave your .pdf version as the item type ‘Manuscript’.

3. Please update the completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"

4. Please amend your]detailed Financial Disclosure statement. This is published with the article, therefore should be completed in full sentences and contain the exact wording you wish to be published.

i) Please include all sources of funding (financial or material support) for your study. List the grants (with grant number) or organizations (with url) that supported your study, including funding received from your institution. 

ii). State the initials, alongside each funding source, of each author to receive each grant.

iii). State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

iv). If any authors received a salary from any of your funders, please state which authors and which funders.

If you did not receive any funding for this study, please simply state: “The authors received no specific funding for this work.”

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have done a good job in this manuscript. The data analysis and presentation is excellent, and also the conclusion is well supported with the data in the results. However, there are some minor corrections required in the general text as follows:

� Lines 152-153: delete “Healthcare providers” and use only its abbreviation because it was already abbreviated in Lines 112-113.

� Lines 179-180: delete “healthcare providers” (line-179) and “healthcare consumers” (line-180) and use only their abbreviations.

� Line 182: long form of UBTH is important to be inserted followed by UBTH in brackets, i.e., University of Benin Teaching Hospital (UBTH). Then, in subsequent areas where UBTH is written in long form, you can replace it with its abbreviation.

� There is a need for consistency in the use of abbreviation for the Coronavirus disease of 2019. In most lines in the Introduction part, authors have used “Covid-19” but in other manuscript sections (including in the abstract), they have used COVID-19. For example, in Lines 185, 241, 279, 282, 286, etc., they used “COVID-19”.

� Lines 380-381: delete “healthcare providers” (line-380) and “healthcare consumers” (line-381) and use only their abbreviations.

� Line 414: “responses from healthcare providers and healthcare consumers,”, the authors need to use the abbreviations for HCP and HCC instead of their long-form.

� Line 417: “telemedicine uptake, previous studies have reported that healthcare providers” – use HCP instead of its long form.

� Line 420: “telemedicine for healthcare consumers is a critical factor in telemedicine uptake” – use HCC instead of its long form.

� Line 434: “Nigerian healthcare providers and the general public. This information is critical” – replace “healthcare providers” with HCP after the word “Nigerian”.

� Line 442: “be generalizable to the healthcare providers and the public in Nigeria. However,” – replace “healthcare provider” with HCP.

� Lines 450-452: “using an online survey. Notwithstanding the limitations, the results of this study provide information providers' and individuals' perceptions on the use of telemedicine due to the coronavirus pandemic.” I SUGGEST THAT THE AUTHORS NEED TO REPHRASE IT TO READ AS FOLLOWS: ““using an online survey. Notwithstanding the limitations, the results of this study provide information REGARDING providers' and individuals' perceptions on the use of telemedicine due to the (((DELETE THIS coronavirus and insert))) COVID-19 pandemic.”

� Lines 464-465: “barriers. In this study, most participants, healthcare providers, and healthcare consumers expressed positive…….” – replace “healthcare providers, and healthcare consumers” with “HCP and HCC”.

Reviewer #2: The author of the paper has done good work. The issues identified are:-

1. Study population is not clear. How many health care providers were sampled and how they identified, also to the healthcare consumers. how was their conduct obtained e.g. mobile number or how did participants both HCP and

3. How easy was healthcare consumers getting health providers conducts like phones and how was the consumers able to authenticate the numbers. Consumers recruited to the social media used to even deliver google forms used?. What was the response rate? Was stratification of the samples

2. Only one question for healthcare consumers as per the chart.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Eliudi Saria Eliakimu

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0000189.r003

Decision Letter 1

Joao Tiago da Silva Botelho, Julia Robinson

19 Jan 2022

Healthcare provider-to-Patient perspectives on the uptake of Teleconsultation services in the Nigerian healthcare system during the COVID-19 pandemic era

PGPH-D-21-00917R1

Dear Dr. EZEONWUMELU,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at https://www.editorialmanager.com/pgph/ click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Kind regards,

Joao Tiago da Silva Botelho

Academic Editor

PLOS Global Public Health

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Eliudi Saria Eliakimu

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Survey. HCP questionnaire.

    (DOCX)

    S2 Survey. HCC questionnaire.

    (DOCX)

    S1 Checklist. PLOS questionnaire on inclusivity in global research.

    (DOCX)

    S1 Table. Results-association between healthcare providers demographic characteristics and perceptions on telemedicine use.

    (DOCX)

    S2 Table. Results-association between healthcare providers demographic characteristics and perceptions on benefits of telemedicine use.

    (DOCX)

    S3 Table. Results-association between healthcare consumers demographic characteristics and perceptions on telemedicine use.

    (DOCX)

    S4 Table. Results-association between healthcare consumers demographic characteristics and perceptions on benefits of telemedicine use.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    All relevant data are within the manuscript and supplementary information.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES